ABSTRACT Background and Aims Cocaine use disorder (CUD) is a significant public health
concern for which no efficacious pharmacological interventions are available. Cannabidiol …

Background Cocaine use disorder (CUD) is associated with various cognitive deficits that
impede patients' functionality, prognosis and therapeutic outcomes. New pharmacological …

Background Cannabinoids may have an important therapeutic potential for the treatment of
dependence on crack cocaine. Cannabidiol (CBD), in particular, has anxiolytic …

Objective: To assess the efficacy of cannabidiol (CBD) in the management of crack-cocaine
craving and the treatment of frequent withdrawal symptoms. Methods: Thirty-one men with a …

Drug addiction is a chronically relapsing disorder characterized by the compulsive desire to
use drugs and a loss of control over consumption. Cannabidiol (CBD), the second most …

Introduction Cannabidiol (CBD) is a phytocannabinoid found in the Cannabis plant. CBD
has received significant medical attention in relation to its anticonvulsant, anxiolytic, and …

Objective The drug poisoning crisis throughout North America necessitates novel harm
reduction approaches. Emerging evidence suggests that cannabidiol (CBD) may have some …

Background Cannabidiol (CBD) is one of the major constituents of Cannabis sativa L. that
lacks psychotomimetic and rewarding properties and inhibits the rewarding and reinforcing …

Cannabidiol is a non-psychoactive compound that is the second most abundant component
of cannabis. It has been shown to have a potential therapeutic value for a wide range of …

Objective: Despite the staggering consequences of the opioid epidemic, limited nonopioid
medication options have been developed to treat this medical and public health crisis. This …